Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 2355
117th Congress(2021-2022)
Opioid Prescription Verification Act of 2021
Active
Active
Passed House on Dec 8, 2021
Overview
Text
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 2355 (Reported-in-House)

Union Calendar No. 130

117th CONGRESS
1st Session
H. R. 2355

[Report No. 117–180]


To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

April 5, 2021

Mr. Rodney Davis of Illinois (for himself, Mr. Bilirakis, and Mrs. Wagner) introduced the following bill; which was referred to the Committee on Energy and Commerce

November 30, 2021

Additional sponsors: Mr. Turner, Mr. Kinzinger, Mr. Mooney, Mr. C. Scott Franklin of Florida, Mr. LaMalfa, and Mr. Budd

November 30, 2021

Reported with an amendment; committed to the Committee of the Whole House on the State of the Union and ordered to be printed

[Strike out all after the enacting clause and insert the part printed in italic]

[For text of introduced bill, see copy of bill as introduced on April 5, 2021]

A BILL

To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Opioid Prescription Verification Act of 2021”.

SEC. 2. Materials for training pharmacists on certain circumstances under which a pharmacist may decline to fill a prescription.

(a) Updates to materials.—Section 3212(a) of the SUPPORT for Patients and Communities Act (21 U.S.C. 829 note) is amended by striking “Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate” and inserting “The Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate not later than 1 year after the date of enactment of this Act, and update periodically thereafter”.

(b) Materials included.—Section 3212(b) of the SUPPORT for Patients and Communities Act (21 U.S.C. 829 note) is amended—

(1) by redesignating paragraphs (1) and (2) as paragraphs (2) and (3), respectively; and

(2) by inserting before paragraph (2), as so redesignated, the following new paragraph:

“(1) pharmacists on how to verify the identity of the patient;”.

(c) Materials for training on patient verification .—Section 3212 of the SUPPORT for Patients and Communities Act (21 U.S.C. 829 note) is amended by adding at the end the following new subsection:

“(d) Materials for training on verification of identity.—Not later than 1 year after the date of enactment of this subsection, the Secretary of Health and Human Services, after seeking stakeholder input in accordance with subsection (c), shall—

“(1) update the materials developed under subsection (a) to include information for pharmacists on how to verify the identity the patient; and

“(2) disseminate, as appropriate, the updated materials.”.

SEC. 3. Incentivizing States To facilitate responsible, informed dispensing of controlled substances.

(a) In general.—Section 392A of the Public Health Service Act (42 U.S.C. 280b–1) is amended—

(1) by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and

(2) by inserting after subsection (b) the following new subsection:

“(c) Preference.—In determining the amounts of grants awarded to States under subsections (a) and (b), the Director of the Centers for Disease Control and Prevention may give preference to States in accordance with such criteria as the Director may specify and may choose to give preference to States that—

“(1) maintain a prescription drug monitoring program;

“(2) require prescribers of controlled substances in schedule II, III, or IV to issue such prescriptions electronically, and make such requirement subject to exceptions in the cases listed in section 1860D–4(e)(7)(B) of the Social Security Act; and

“(3) require dispensers of such controlled substances to enter certain information about the purchase of such controlled substances into the respective State’s prescription drug monitoring program, including—

“(A) the National Drug Code or, in the case of compounded medications, compound identifier;

“(B) the quantity dispensed;

“(C) the patient identifier; and

“(D) the date filled.”.

(b) Definitions.—Subsection (d) of section 392A of the Public Health Service Act (42 U.S.C. 280b–1), as redesignated by subsection (a)(1), is amended to read as follows:

“(d) Definitions.—In this section:

“(1) CONTROLLED SUBSTANCE.—The term ‘controlled substance’ has the meaning given that term in section 102 of the Controlled Substances Act.

“(2) DISPENSER.—The term ‘dispenser’ means a physician, pharmacist, or other person that dispenses a controlled substance to an ultimate user.

“(3) INDIAN TRIBE.—The term ‘Indian tribe’ has the meaning given that term in section 4 of the Indian Self-Determination and Education Assistance Act.”.

Union Calendar No. 130

117th CONGRESS
     1st Session
H. R. 2355
[Report No. 117–180]
A BILL
To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.
November 30, 2021
Reported with an amendment; committed to the Committee of the Whole House on the State of the Union and ordered to be printed